Industry Updates

Regulatory Industry Updates

Tuesday, June 8, 2010

Trends in 505(b)(2) Approvals - Contract Pharma

Trends in 505(b)(2) Approvals - Contract Pharma
Posted by RRI Group at 1:04 PM 0 comments
Newer Posts Older Posts Home
Subscribe to: Posts (Atom)

About US

My photo
RRI Group
Lake Wylie, SC, United States
RRI Group, Inc. is a Full Service Global Clinical Trial, Regulatory and Management Company that collaborates with pharmaceutical, device, and biotech companies in the development of novel branded and generic therapeutics and devices. We specializing in 510k,NDA, especially the 505(b)(2), and ANDA programs. RRI Group, Inc. facilitates obtaining FDA approvals by delivering high quality regulatory and clinical strategies, solutions and services, with the demonstrated ability to save our clients time and money. RRI Group, Inc. is headquartered near Charlotte, NC, and has regional offices and associates across the globe. Specialists in Clinical Trials/510k/505(b)(2) NDA/ANDA/Regulatory & Development Services
View my complete profile

Followers

Blog Archive

  • ►  2012 (2)
    • ►  March (2)
  • ▼  2010 (2)
    • ▼  June (1)
      • Trends in 505(b)(2) Approvals - Contract Pharma
    • ►  April (1)

Search This Blog